Experienced in Acid Sphingomyelinase Deficiency (ASMD)

Bernd Bokemeyer

Kiel, SH, DE 
Experienced in Acid Sphingomyelinase Deficiency (ASMD)
Kiel, SH, DE 
OverviewLocationsClinical Research

Overview

Bernd Bokemeyer practices in Kiel, Germany. Mr. Bokemeyer is rated as an Experienced expert by MediFind in the treatment of Acid Sphingomyelinase Deficiency (ASMD). His top areas of expertise are Colitis, Viral Gastroenteritis, Ulcerative Colitis, and Hemorrhagic Proctocolitis.

His clinical research consists of co-authoring 92 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Acid Sphingomyelinase Deficiency (ASMD).

Gender
Male

Locations

Kiel, SH, Germany
Other Locations
Minden, NW, Germany
Jena, TH 07747, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Enrollment Status: Completed
Publish Date: June 21, 2024
Intervention Type: Drug
Study Drug: Ontamalimab
Study Phase: Phase 3
A 2-Week Exploratory Randomized, Double-Blind, Parallel-Group, Dose-Ranging, Placebo-Controlled Safety, Tolerability, Biomarker and Efficacy Clinical Study of PUR 0110 Rectal Enema in Mild-to-Moderate Distal Ulcerative Colitis
A 2-Week Exploratory Randomized, Double-Blind, Parallel-Group, Dose-Ranging, Placebo-Controlled Safety, Tolerability, Biomarker and Efficacy Clinical Study of PUR 0110 Rectal Enema in Mild-to-Moderate Distal Ulcerative Colitis
Enrollment Status: Completed
Publish Date: May 01, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

92 Total Publications

Author response to "Comment on: Burden of coeliac disease in Germany: real world insights from a large retrospective health insurance claims database analysis".
Author response to "Comment on: Burden of coeliac disease in Germany: real world insights from a large retrospective health insurance claims database analysis".
Journal: Therapeutic advances in gastroenterology
Published: June 10, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Bokemeyer's expertise for a condition
ConditionClose
View All 7 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile